Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.
Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain. Reply].
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
Magnetic resonance imaging in multiple sclerosis - patients' experiences, information interests and responses to an education programme.
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis.
Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
High dose naltrexone for dyskinesias induced by levodopa.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
Tysabri
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Receptos provides update on progress of lead product candidate RPC1063
Progressive Multifocal Leukoencephalopathy
Molecular targets of FTY720 (fingolimod).

Pages